Related Experiment Videos
Off-label prescribing in older patients
Stephen H D Jackson1, Paul A F Jansen, Arduino A Mangoni
1Department of Clinical Gerontology, Kings Health Partners Academic Health Science Centre, London, UK. stephen.jackson@kcl.ac.uk
Drugs & Aging
|May 31, 2012
Summary
Off-label prescribing is common in older adults due to limited clinical trial data. Careful consideration of evidence and risk mitigation strategies are essential for safe and effective use of these medications.
Area of Science:
- Geriatrics
- Clinical Pharmacology
- Evidence-Based Medicine
Background:
- Off-label prescribing is prevalent in older patients, often due to their underrepresentation in clinical trials.
- This practice involves using medications for unapproved indications, dosages, or age groups.
Purpose of the Study:
- To discuss the epidemiology and trends of off-label prescribing in the elderly.
- To examine the scientific and ethical basis for off-label drug use.
- To explore medico-legal aspects and risk mitigation strategies.
Main Methods:
- Review of current literature on off-label prescribing in older populations.
- Analysis of scientific and ethical considerations.
- Discussion of legal implications and safety protocols.
Main Results:
- Off-label prescribing in older adults is common and influenced by trial data limitations.
- The practice can be scientifically and ethically justified with adequate clinical evidence.
- Risk mitigation strategies are crucial to ensure efficacy and minimize adverse events.
Conclusions:
- Off-label prescribing in older patients requires careful evaluation of evidence.
- Implementing risk mitigation strategies is vital for patient safety and legal protection.
- Further research may be needed to address data gaps in this population.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...